Results 121 to 130 of about 9,057,173 (269)

Machine learning for identifying liver and pancreas cancers through comprehensive serum glycopeptide spectra analysis: a case‐control study

Molecular Oncology, EarlyView.
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima, Yuko Takami, Ken Kawabe, Kazuhiro Tanabe, Chihiro Hayashi, Mikio Mikami, Tetsuya Kusumoto   +6 more
wiley   +1 more source

A rare case of factor X deficiency induced by valproic acid. [PDF]

Res Pract Thromb Haemost
Rigon PA, Ernest V.
europepmc   +1 more source

Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics. [PDF]

J Thromb Thrombolysis, 2021
Camire RM.
europepmc   +1 more source

X-RAY SCATTERING FACTORS COMPUTED FROM NUMERICAL HARTREE--FOCK WAVE FUNCTIONS.

, 1967
D. T. Cromer, J. B. Mann
openalex   +2 more sources

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

Molecular Oncology, EarlyView.
Cyclin D1 overexpression altered the cell adhesion pathway, while cyclin D2 upregulation had less impact on pathway enrichment analysis. Multiple myeloma (MM) patients with cyclin D1 overexpression showed reduced CD56 expression and increased circulating tumor cells (CTC) levels, suggesting that cyclin D1 may contribute to MM cell dissemination ...
Ignacio J. Cardona‐Benavides, Sara Cristobal‐Vargas, Cristina De Ramón, Elizabeta A. Rojas, Irena Misiewicz‐Krzeminska, Isabel Isidro, José Juan Pérez, Bruno Paiva, Noemi Puig, Miguel Alcoceba, María‐Victoria Mateos, Luis A. Corchete, Myriam Cuadrado, Norma C. Gutiérrez   +13 more
wiley   +1 more source

Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency. [PDF]

Hematol Rep
Ross A, Shaw RJ, Garth L, Farrelly C.
europepmc   +1 more source

miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X. [PDF]

Dis Markers, 2022
Xia S, Wang X, Wu Y, Zhou T, Tian H, Liu Z, Li L, Yan Z, Zhang G.   +8 more
europepmc   +1 more source

Factor in Serum inhibiting Bone Marrow Mitoses after X-irradiation of the Spleen

, 1966
B. DALOS
openalex   +1 more source

Comprehensive profiling of lncRNAs and mRNAs enriched in small extracellular vesicles for early noninvasive detection of colorectal cancer: diagnostic panel assembly and extensive validation

Molecular Oncology, EarlyView.
Small extracellular vesicles are a promising source of diagnostic molecules. We conducted a comprehensive study, including transcriptome profiling and RT‐qPCR validation on large cohorts of samples. Diagnostic panels enabling sensitive detection of colorectal cancer and precancerous lesions were established. Some molecules were differentially expressed
Petra Vychytilova‐Faltejskova, Marketa Pavlikova, Lucie Pifkova, Robin Jugas, Tana Machackova, Lenka Radova, Milana Sachlova, Renata Bartosova, Tetiana Samoilenko, Zuzana Feckova, Jana Orlickova, Erika Slamova, Elleni Ponechal Michu, Dagmar Al Tukmachi, Michaela Ruckova, Martina Vodinska, Jan Kotoucek, Tina Catela Ivkovic, Marie Boudna, Lucia Bohovicova, Teodor Stanek, Jana Halamkova, Martin Svoboda, Vladimir Prochazka, Tomas Grolich, Zdenek Kala, Ondrej Slaby   +26 more
wiley   +1 more source

A new look at TFPI inhibition of factor X activation. [PDF]

PLoS Comput Biol
Santiago F, Kaur A, Bride S, Monroe D, Leiderman K, Sindi S.   +5 more
europepmc   +1 more source